Your browser doesn't support javascript.
loading
A rare presentation of choroidal metastasis from primary esophageal adenocarcinoma successfully treated with intensity-modulated radiation therapy.
Date, Rishabh C; Adams, Matthew K; Teh, Bin S; Schefler, Amy C; Musher, Benjamin L; Farach, Andrew; Weng, Christina Y.
Afiliación
  • Date RC; Department of Ophthalmology, Baylor College of Medicine, 6565 Fannin St., NC-205, Houston, TX 77030, USA.
  • Adams MK; Department of Ophthalmology, Baylor College of Medicine, 6565 Fannin St., NC-205, Houston, TX 77030, USA.
  • Teh BS; Department of Radiation Oncology, Houston Methodist Hospital, 6565 Fannin St., DB1-077, Houston, TX 77030, USA.
  • Schefler AC; Retina Consultants of Houston, 6560 Fannin Street, Suite 750, Houston, TX 77030, USA.
  • Musher BL; Blanton Eye Institute, Houston Methodist Hospital, 6500 Fannin Street, Houston, TX 77030, USA.
  • Farach A; Department of Medicine, Baylor College of Medicine, Dan L. Duncan Comprehensive Cancer Center, 6620 Main St., Suite 1350, Houston, TX 77030, USA.
  • Weng CY; Department of Radiation Oncology, Houston Methodist Hospital, 6565 Fannin St., DB1-077, Houston, TX 77030, USA.
Am J Ophthalmol Case Rep ; 11: 19-22, 2018 Sep.
Article en En | MEDLINE | ID: mdl-30057967
PURPOSE: In this case report, we present a case of choroidal metastasis from a primary esophageal adenocarcinoma that was treated successfully with intensity-modulated radiation therapy. OBSERVATIONS: A 65-year-old male with known stage IV esophageal adenocarcinoma presented with a central scotoma in his left eye and was ultimately found to have a large choroidal metastatic lesion with overlying subretinal fluid. IMRT was administered over the course of four weeks, resulting in restoration of the patient's vision, regression of the metastatic lesion, and resolution of the subretinal fluid. As of 16 months following completion of radiation, there remains no evidence of choroidal recurrence or radiation-associated ocular complications. CONCLUSIONS: and Importance: To our knowledge, this is the first published case report of a choroidal metastasis from esophageal cancer responding durably to IMRT. IMRT should therefore be considered a viable treatment option for this rare disease.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Ophthalmol Case Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Am J Ophthalmol Case Rep Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
...